Phase 3 Hepatitis B Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with chronic hepatitis B according to specific Chinese medical guidelines, and who have tested positive for two hepatitis B markers (called HBeAg and HBsAg) for at least six months continuously
- People whose hepatitis B virus levels in the blood are above a certain threshold (HBV DNA > 20,000 copies/mL) and whose HBsAg level is below a certain threshold (< 1,500 IU/mL) (confirm with trial site)
- People whose liver enzyme levels (specifically ALT) are more than twice the upper limit of the normal range, indicating some liver inflammation
- People who have not received any antiviral treatment before entering the study
Who may not be able to join:
- People who are also infected with other liver-affecting viruses, such as hepatitis A, C, D, or E, or who have HIV
- People who have other liver conditions, cirrhosis, autoimmune diseases, or other ongoing chronic health conditions
- People who are pregnant, breastfeeding, or planning to become pregnant within one year
- People who have received or are currently receiving cancer treatment
- People with a history of alcohol or drug abuse
- People who are currently taking any medications or health supplements
- People who participated in another clinical trial within the 30 days before enrolling in this study
- People who have a history of allergic reactions or known sensitivity to any drug or ingredient used in this study
- People who have digestive or gastrointestinal conditions that may affect how the body absorbs medication
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +8618703636245
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Follow-up at 12 months
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.